This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: John F. McElroy: Innovator in Cannabinoid Research
Introduction
John F. McElroy is a notable inventor based in the United States, recognized for his contributions to the field of cannabinoid research. His work primarily focuses on developing novel compounds that can aid in treating metabolic disorders, including obesity and diabetes.
Latest Patents
Although John F. McElroy currently holds no patents, he has been involved in significant research that led to the development of cannabinoid receptor antagonists and inverse agonists. His notable invention, titled "Cannabinoid Receptor Antagonists/Inverse Agonists Useful For Treating Metabolic Disorders, Including Obesity And Diabetes," presents innovative pyrazoles that serve as cannabinoid receptor antagonists. This invention outlines pharmaceutical compositions and methods for treating obesity, diabetes, and cardiometabolic disorders.
Career Highlights
John F. McElroy is associated with Jenrin Discovery, Inc., where he has been instrumental in advancing research in cannabinoid therapies. His work has the potential to impact the treatment landscape for metabolic disorders significantly.
Collaborations
John collaborates with Robert J. Chorvat, contributing to the innovative research environment at Jenrin Discovery, Inc.
Conclusion
John F. McElroy's work in cannabinoid research highlights the potential for innovative treatments for metabolic disorders. His contributions to the field are paving the way for future advancements in pharmaceutical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile